Results 21 to 30 of about 11,498 (161)

Comparison of modified-release hydrocortisone capsules versus prednisolone in the treatment of congenital adrenal hyperplasia

open access: yesEndocrine Connections
Background: Prednisolone and prednisone are recommended treatment options for adults with congenital adrenal hyperplasia (CAH); however, there is no randomised comparison of prednis(ol)one with hydrocortisone.
Aled Daffyd Rees   +14 more
doaj   +1 more source

Measurement of serum tenascin-X in patients with congenital adrenal hyperplasia at risk for Ehlers–Danlos contiguous gene deletion syndrome CAH-X

open access: yesBMC Research Notes, 2019
Objective Approximately 10% of patients with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency carry a mutation that disrupts CYP21A2 and the flanking TNXB gene resulting in CAH-X, a contiguous gene deletion syndrome.
Vipula Kolli   +6 more
doaj   +1 more source

PERSPECTIVE: Treatment with hydrocortisone modified-release capsules in children and adolescents with congenital adrenal hyperplasia: an expert opinion

open access: yesEndocrine Connections
Recommended treatment for classic congenital adrenal hyperplasia (CAH) in children is hydrocortisone. This therapy is intended to replace cortisol deficiency, but also to reduce the increased production of androgens and their precursors.
U Neumann   +2 more
doaj   +1 more source

Aminothiol supported dialdehyde cellulose for efficient and selective removal of Hg(II) from aquatic solutions

open access: yesScientific Reports, 2023
The increasingly serious problem of mercury pollution has caused wide concern, and exploring adsorbent materials with high adsorption capacity is a simple and effective approach to address this concern.
Aya G. Mostafa   +2 more
doaj   +1 more source

Screening for Anxiety and Depression in Children with Congenital Adrenal Hyperplasia

open access: yesJCRPE, 2023
INTRODUCTION: Congenital adrenal hyperplasia (CAH) is an inherited condition in which individuals require multiple daily doses of medication and are at risk for life-threatening adrenal crisis.
Marianne Jacob   +5 more
doaj   +1 more source

Congenital adrenal hyperplasia with homozygous and heterozygous mutations: a rare family case report

open access: yesBMC Endocrine Disorders, 2022
Background Congenital adrenal hyperplasia (CAH), characterized by defective adrenal steroidogenesis, is transmitted in an autosomal recessive manner. Mutations in the steroid 21-hydroxylase gene CYP21A2 causing steroid 21-hydroxylase deficiency account ...
Tiantian Cheng   +4 more
doaj   +1 more source

Phenomenology of the CAH+ measure

open access: yesPhysical Review D, 2011
35 pages, including 6 figures and 2 appendices; v2 corrections in Section 2.4, conclusions ...
Salem, Michael P., Vilenkin, Alexander
openaire   +3 more sources

Should CAH in Females Be Classified as DSD? [PDF]

open access: yesFrontiers in Pediatrics, 2016
Great controversies and misunderstandings have developed around the relatively recently coined term disorders of sex development (DSD). In this article, we question the wisdom of including XX individuals with congenital adrenal hyperplasia (CAH) in the DSD category and develop arguments against it based on the published literature on the subject. It is
Ricardo eGonzález   +1 more
openaire   +3 more sources

Variabilité des facteurs antinutritionnels des composés phytochimiques bioactifs et de la composition minérale chez des lignées mutantes de soja (Glycine max L.) développées par mutagenèse induite en République Démocratique du Congo.

open access: yesRevue des Sciences de la Santé
La malnutrition et les carences en micronutriments, notamment en fer et en zinc, demeurent des défis majeurs de santé publique en République Démocratique du Congo (RDC).
Ornella VONZAYA MAKAYA   +10 more
doaj   +1 more source

Metabolic Perspectives for Non-classical Congenital Adrenal Hyperplasia With Relation to the Classical Form of the Disease

open access: yesFrontiers in Endocrinology, 2019
Non-classical congenital adrenal hyperplasia (NC-CAH) represents mild form of CAH with the prevalence of 0. 6 to 9% in women with androgen excess. Clinical and hormonal findings in females with NC-CAH are overlapping with other hyperandrogenic entities ...
Djuro Macut   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy